Business & Industry

German pharmaceutical company Boehringer Ingelheim has reported that its experimental obesity drug, survodutide, significantly reduced visceral abdominal fat and liver fat while largely preserving lean body mass in a late-stage clinical study. The data strengthens the company's argument that...

CytomX Therapeutics and Regeneron Pharmaceuticals have expanded their ongoing research collaboration focused on developing tumor-activated bispecific cancer therapy candidates, broadening the scope of an agreement that was originally established in 2019. The expanded collaboration introduces additional bispecific targets into...

Pfizer has entered into a licensing agreement with Chai Discovery, granting the pharmaceutical giant access to Chai's generative AI platform for integration into its drug discovery operations. The deal provides Pfizer with early access to the newly revealed Chai-3...

Eli Lilly has entered into a research collaboration with Ascidian Therapeutics aimed at discovering and developing treatments for kidney diseases, marking another step in the company’s ongoing genetic medicine strategy. The agreement, which could be worth up to $1.9bn for...

Informa Markets has announced that CPHI Americas will relocate to Miami in 2027, marking a significant step in the event’s ongoing development as a platform for pharmaceutical innovation, outsourcing and strategic partnerships. Scheduled for May 25-26, 2027, at the...

Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant's field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi's field agents faster, more efficient...

Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in...